BIOTW

Biotech Acquisition Company Warrant
BIOTW

Delisted

BIOTW was delisted on the 2nd of February, 2023.

52 hedge funds and large institutions have $5.06M invested in Biotech Acquisition Company Warrant in 2022 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 11 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
52
Holders Change
-4
Holders Change %
-7.14%
% of All Funds
0.82%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
9
Reduced
11
Closed
9
Calls
$5.74M
Puts
Net Calls
+$5.74M
Net Calls Change
-$37K
Name Holding Trade Value Shares
Change
Shares
Change %
OCAM
51
Owl Creek Asset Management
New York
$2K +$2K +10,000 New
UBS Group
52
UBS Group
Switzerland
$1K -$76 -190 -7%
RA
53
Ramius Advisors
New York
-$299K -452,674 Closed
Blackstone Inc
54
Blackstone Inc
New York
-$165K -250,000 Closed
FTCM
55
Fir Tree Capital Management
New York
-$82K -125,409 Closed
AGM
56
Alpine Global Management
New York
-$67K -103,502 Closed
PSAMP
57
P. Schoenfeld Asset Management (PSAM)
New York
-$66K -100,000 Closed
GCL
58
Glazer Capital LLC
New York
-$52K -79,079 Closed
CCFM
59
Cohen & Co Financial Management
New York
-$33K -50,000 Closed
PCM
60
Prelude Capital Management
New York
-$12K -18,154 Closed
MIG
61
Mariner Investment Group
New York
-$7K -10,000 Closed
JPMorgan Chase & Co
62
JPMorgan Chase & Co
New York
-$47K